SGLT2 Inhibitors in Type 2 Diabetes Mellitus

被引：3
|
作者：
Ferrannini, Giulia [1 ]
Savarese, Gianluigi [1 ,2 ]
Cosentino, Francesco [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Med, Div Cardiol, Norrbacka S1 02, SE-17177 Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Cardiol, Heart Vasc & Neuro Theme, Anna Stecksens Gata 41, S-17164 Solna, Sweden
来源：
HEART FAILURE CLINICS | 2022年 / 18卷 / 04期
关键词：
Sodium-glucose cotransporter 2 inhibitors; Type; 2; diabetes; Cardiovascular outcomes; Heart failure; COTRANSPORTER; 2; INHIBITORS; HEART-FAILURE; CARDIOVASCULAR RISK; GLUCOSE TRANSPORTERS; MORTALITY INSIGHTS; NA+/H+ EXCHANGER; BLOOD-PRESSURE; DOUBLE-BLIND; EMPAGLIFLOZIN; DEATH;
D O I：
10.1016/j.hfc.2022.03.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：551 / 559
页数：9
相关论文
共 50 条
  • [1] Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
    Solini, Anna
    [J]. ACTA DIABETOLOGICA, 2016, 53 (06) : 863 - 870
  • [2] Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
    Anna Solini
    [J]. Acta Diabetologica, 2016, 53 : 863 - 870
  • [3] SGLT2 Inhibitors for Type 2 Diabetes
    Liu, Jiwen
    Lee, TaeWeon
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
  • [4] Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    [J]. CURRENT DIABETES REPORTS, 2012, 12 (03) : 230 - 238
  • [5] The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors
    Weir, Matthew R.
    [J]. POSTGRADUATE MEDICINE, 2016, 128 (03) : 290 - 298
  • [6] Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Muhammad A. Abdul-Ghani
    Luke Norton
    Ralph A. DeFronzo
    [J]. Current Diabetes Reports, 2012, 12 : 230 - 238
  • [7] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [8] SGLT2 inhibitors in the management of type 2 diabetes
    Reddy, R. P. Monica
    Inzucchi, Silvio E.
    [J]. ENDOCRINE, 2016, 53 (02) : 364 - 372
  • [9] SGLT2 inhibitors in the management of type 2 diabetes
    R. P. Monica Reddy
    Silvio E. Inzucchi
    [J]. Endocrine, 2016, 53 : 364 - 372
  • [10] Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
    Singh, Mahakpreet
    Sharma, Ruchika
    Kumar, Anoop
    [J]. CURRENT DRUG SAFETY, 2019, 14 (02) : 87 - 93
12345